[Answered] Postural hypotension in patients taking drugs that promote venous dilation is: a. averted by ...

This topic contains a solution. Click here to go to the answer

Author Question: Postural hypotension in patients taking drugs that promote venous dilation is: a. averted by ... (Read 44 times)

Wadzanai

Hero Member
Posts: 528

on: Jul 23, 2018

Postural hypotension in patients taking drugs that promote venous dilation is:

a. averted by gravity.
b. more intense and prolonged.
c. diminished by the drugs.
d. shorter in duration.

Question 2

When the baroreceptor reflex is activated:

a. arterioles dilate.
b. venous return decreases.
c. heart rate increases.
d. peripheral resistance decreases.

Need homework help now?

Ask unlimited questions for free

Ask a Question

Marked as best answer by a Subject Expert

momtoalll

Sr. Member
Posts: 326

Reply #1 on: Jul 23, 2018

Answer to Question 1

b

Answer to Question 2

c

Wadzanai

Member
Posts: 528

Reply 2 on: Jul 23, 2018

Great answer, keep it coming

Bigfoot1984

Member
Posts: 321

Reply 3 on: Yesterday

Wow, this really help

« previous next »

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

Did you know?

As many as 28% of hospitalized patients requiring mechanical ventilators to help them breathe (for more than 48 hours) will develop ventilator-associated pneumonia. Current therapy involves intravenous antibiotics, but new antibiotics that can be inhaled (and more directly treat the infection) are being developed.

Did you know?

There are more sensory neurons in the tongue than in any other part of the body.

Did you know?

The Romans did not use numerals to indicate fractions but instead used words to indicate parts of a whole.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.